Literature DB >> 20625451

Concise Two-Step Solution Phase Syntheses of four novel Dihydroquinazoline scaffolds.

Justin Dietrich1, Christine Kaiser, Nathalie Meurice, Christopher Hulme.   

Abstract

Novel two-step solution phase protocols for the synthesis of dihydroquinazolines and fused dihydroquinazoline-benzodiazepine tetracycles are reported. The methodology employs the Ugi reaction to assemble desired diversity and acid treatment enables ring closing transformations. The protocols are further facilitated by the use of microwave irradiation and n-butyl isocyanide to control the rate of each ring forming transformation.

Entities:  

Year:  2010        PMID: 20625451      PMCID: PMC2897742          DOI: 10.1016/j.tetlet.2010.05.108

Source DB:  PubMed          Journal:  Tetrahedron Lett        ISSN: 0040-4039            Impact factor:   2.415


  16 in total

1.  Maximizing synthetic efficiency: multi-component transformations lead the way

Authors: 
Journal:  Chemistry       Date:  2000-09-15       Impact factor: 5.236

2.  Drug discovery of the future: the implications of the human genome project.

Authors:  T Reiss
Journal:  Trends Biotechnol       Date:  2001-12       Impact factor: 19.536

3.  Significance of the human genome sequence to drug discovery.

Authors:  O Grenet
Journal:  Pharmacogenomics J       Date:  2001       Impact factor: 3.550

Review 4.  "Multi-component reactions : emerging chemistry in drug discovery" 'from xylocain to crixivan'.

Authors:  Christopher Hulme; Vijay Gore
Journal:  Curr Med Chem       Date:  2003-01       Impact factor: 4.530

5.  2,5-diketopiperazines as potent, selective, and orally bioavailable oxytocin antagonists. 2. Synthesis, chirality, and pharmacokinetics.

Authors:  Alan D Borthwick; Dave E Davies; Anne M Exall; David G Livermore; Steve L Sollis; Fabrizio Nerozzi; Michael J Allen; Marion Perren; Shalia S Shabbir; Patrick M Woollard; Paul G Wyatt
Journal:  J Med Chem       Date:  2005-11-03       Impact factor: 7.446

6.  The discovery of GSK221149A: a potent and selective oxytocin antagonist.

Authors:  John Liddle; Michael J Allen; Alan D Borthwick; David P Brooks; David E Davies; Richard M Edwards; Anne M Exall; Chris Hamlett; Wendy R Irving; Andrew M Mason; Gerald P McCafferty; Fabrizio Nerozzi; Simon Peace; Joanne Philp; Derek Pollard; Mark A Pullen; Shaila S Shabbir; Steve L Sollis; Timothy D Westfall; Pat M Woollard; Charlene Wu; Deirdre M B Hickey
Journal:  Bioorg Med Chem Lett       Date:  2007-11-06       Impact factor: 2.823

7.  Molecular diversity: from small to large, emerging to enabling.

Authors:  Christopher Hulme; Gerald M Maggiora
Journal:  Curr Opin Chem Biol       Date:  2008-05-20       Impact factor: 8.822

8.  2,5-diketopiperazines as potent, selective, and orally bioavailable oxytocin antagonists. 3. Synthesis, pharmacokinetics, and in vivo potency.

Authors:  Alan D Borthwick; Dave E Davies; Anne M Exall; Richard J D Hatley; Jennifer A Hughes; Wendy R Irving; David G Livermore; Steve L Sollis; Fabrizio Nerozzi; Klara L Valko; Michael J Allen; Marion Perren; Shalia S Shabbir; Patrick M Woollard; Mark A Price
Journal:  J Med Chem       Date:  2006-07-13       Impact factor: 7.446

Review 9.  Rapid assembly of molecular diversity via exploitation of isocyanide-based multi-component reactions.

Authors:  Christopher Hulme; Thomas Nixey
Journal:  Curr Opin Drug Discov Devel       Date:  2003-11

Review 10.  Emerging molecular diversity from the intra-molecular Ugi reaction: iterative efficiency in medicinal chemistry.

Authors:  Christopher Hulme; Justin Dietrich
Journal:  Mol Divers       Date:  2009-02-11       Impact factor: 3.364

View more
  7 in total

1.  A novel route to synthesize libraries of quinoxalines via Petasis methodology in two synthetic operations.

Authors:  Muhammad Ayaz; Justin Dietrich; Christopher Hulme
Journal:  Tetrahedron Lett       Date:  2011-09-21       Impact factor: 2.415

2.  General one-pot, two-step protocol accessing a range of novel polycyclic heterocycles with high skeletal diversity.

Authors:  Zhigang Xu; Muhammad Ayaz; Alexandra A Cappelli; Christopher Hulme
Journal:  ACS Comb Sci       Date:  2012-07-12       Impact factor: 3.784

3.  Straightforward assembly of phenylimidazoquinoxalines via a one-pot two-step MCR process.

Authors:  Fabio De Moliner; Christopher Hulme
Journal:  Org Lett       Date:  2012-02-22       Impact factor: 6.005

4.  Recent Advances in the Development of Catalytic Methods that Construct Medium-ring Lactams, Partially Saturated Benzazepines and their Derivatives.

Authors:  Wrickban Mazumdar; Tom G Driver
Journal:  Synthesis (Stuttg)       Date:  2021       Impact factor: 3.157

Review 5.  Two decades of recent advances of Ugi reactions: synthetic and pharmaceutical applications.

Authors:  Manar Ahmed Fouad; Hamida Abdel-Hamid; Mohammed Salah Ayoup
Journal:  RSC Adv       Date:  2020-11-23       Impact factor: 4.036

6.  Syntheses of 3,4- and 1,4-dihydroquinazolines from 2-aminobenzylamine.

Authors:  Jimena E Díaz; Silvia Ranieri; Nadia Gruber; Liliana R Orelli
Journal:  Beilstein J Org Chem       Date:  2017-07-27       Impact factor: 2.883

7.  Synthesis of dihydroquinazolines from 2-aminobenzylamine: N 3 -aryl derivatives with electron-withdrawing groups.

Authors:  Nadia Gruber; Jimena E Díaz; Liliana R Orelli
Journal:  Beilstein J Org Chem       Date:  2018-09-26       Impact factor: 2.883

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.